{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T03:22:48Z","timestamp":1775186568497,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,7,3]],"date-time":"2012-07-03T00:00:00Z","timestamp":1341273600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1007\/s00428-012-1273-4","type":"journal-article","created":{"date-parts":[[2012,8,9]],"date-time":"2012-08-09T10:22:53Z","timestamp":1344507773000},"page":"109-116","source":"Crossref","is-referenced-by-count":17,"title":["Anterior gradient protein 2 (AGR2) is an independent prognostic factor in ovarian high-grade serous carcinoma"],"prefix":"10.1007","volume":"461","author":[{"given":"S.","family":"Darb-Esfahani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Fritzsche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Kristiansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Weichert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Sehouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Braicu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Dietel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Denkert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,7,3]]},"reference":[{"key":"1273_CR1","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrc2644","volume":"9","author":"RC Bast Jr","year":"2009","unstructured":"Bast RC Jr, Hennessy B, Mills GB (2009) The biology of ovarian cancer: new opportunities for translation. Nat Rev Cancer 9:415\u2013428","journal-title":"Nat Rev Cancer"},{"key":"1273_CR2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00428-012-1203-5","volume":"460","author":"J Prat","year":"2012","unstructured":"Prat J (2012) Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features. Virchows Arch 460:237\u2013249","journal-title":"Virchows Arch"},{"key":"1273_CR3","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","volume":"474","author":"Cancer Genome Atlas Research Network","year":"2011","unstructured":"Cancer Genome Atlas Research Network (2011) Integrated genomic analyses of ovarian carcinoma. Nature 474:609\u2013615","journal-title":"Nature"},{"key":"1273_CR4","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/IGC.0b013e31821ce75d","volume":"21","author":"T Thigpen","year":"2011","unstructured":"Thigpen T, duBois A, McAlpine J, DiSaia P, Fujiwara K, Hoskins W, Kristensen G, Mannel R, Markman M, Pfisterer J, Quinn M, Reed N, Swart AM, Berek J, Colombo N, Freyer G, Gallardo D, Plante M, Poveda A, Rubinstein L, Bacon M, Kitchener H, Stuart GC, Gynecologic Cancer InterGroup (2011) First-line therapy in ovarian cancer trials. Int J Gynecol Cancer 21:756\u2013762","journal-title":"Int J Gynecol Cancer"},{"key":"1273_CR5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0092-8674(89)90413-3","volume":"58","author":"HL Sive","year":"1989","unstructured":"Sive HL, Hattori K, Weintraub H (1989) Progressive determination during formation of the anteroposterior axis in Xenopus laevis. Cell 58:171\u2013180","journal-title":"Cell"},{"key":"1273_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2010.12.023","volume":"304","author":"V Brychtova","year":"2011","unstructured":"Brychtova V, Vojtesek B, Hrstka R (2011) Anterior gradient 2: a novel player in tumor cell biology. Cancer Lett 304:1\u20137","journal-title":"Cancer Lett"},{"key":"1273_CR7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1006\/bbrc.1998.9440","volume":"251","author":"DA Thompson","year":"1998","unstructured":"Thompson DA, Weigel RJ (1998) hAG-2, the human homologue of the Xenopus laevis cement gland gene XAG-2, is coexpressed with estrogen receptor in breast cancer cell lines. Biochem Biophys Res Commun 251:111\u2013116","journal-title":"Biochem Biophys Res Commun"},{"key":"1273_CR8","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/sj.bjc.6603065","volume":"94","author":"HE Innes","year":"2006","unstructured":"Innes HE, Liu D, Barraclough R, Davies MP, O'Neill PA, Platt-Higgins A, deSilva RS, Sibson DR, Rudland PS (2006) Significance of the metastasis-inducing protein AGR2 for outcome in hormonally treated breast cancer patients. Br J Cancer 94:1057\u20131065","journal-title":"Br J Cancer"},{"key":"1273_CR9","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.2353\/ajpath.2009.090246","volume":"175","author":"DL Barraclough","year":"2009","unstructured":"Barraclough DL, Platt-Higgins A, de Silva RS, Barraclough R, WinstanleyJ WCR, Rudland PS (2009) The metastasis-associated anterior gradient 2 protein is correlated with poor survival of breast cancer patients. Am J Pathol 175:1848\u20131857","journal-title":"Am J Pathol"},{"key":"1273_CR10","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1158\/1078-0432.CCR-05-2057","volume":"12","author":"FR Fritzsche","year":"2006","unstructured":"Fritzsche FR, Dahl E, Pahl S, Burkhardt M, Luo J, Mayordomo E, Gansukh T, Dankof A, Knuechel R, Denkert C, Winzer KJ, Dietel M, Kristiansen G (2006) Prognostic relevance of AGR2 expression in breast cancer. Clin Cancer Res 12:1728\u20131734","journal-title":"Clin Cancer Res"},{"key":"1273_CR11","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.1038\/onc.2010.228","volume":"29","author":"R Hrstka","year":"2010","unstructured":"Hrstka R, Nenutil R, Fourtouna A, Maslon MM, Naughton C, Langdon S, Murray E, Larionov A, Petrakova K, Muller P, Dixon MJ, Hupp TR, Vojtesek B (2010) The pro-metastatic protein anterior gradient-2 predicts poor prognosis in tamoxifen-treated breast cancers. Oncogene 29:4838\u20134847","journal-title":"Oncogene"},{"key":"1273_CR12","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/path.1676","volume":"205","author":"G Kristiansen","year":"2005","unstructured":"Kristiansen G, Pilarsky C, Wissmann C, Kaiser S, Bruemmendorf T, Roepcke S, Dahl E, Hinzmann B, Specht T, Pervan J, Stephan C, Loening S, Dietel M, Rosenthal A (2005) Expression profiling of microdissected matched prostate cancer samples revealsCD166\/MEMD and CD24 as new prognostic markers for patient survival. J Pathol 205:359\u2013376","journal-title":"J Pathol"},{"key":"1273_CR13","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/pros.21273","volume":"71","author":"H Bu","year":"2011","unstructured":"Bu H, Bormann S, Sch\u00e4fer G, Horninger W, Massoner P, Neeb A, Lakshmanan VK, Maddalo D, Nestl A, S\u00fcltmann H, Cato AC, Klocker H (2011) The anterior gradient 2 (AGR2) gene is overexpressed in prostate cancer and may be useful as a urine sediment marker for prostate cancer detection. Prostate 71:575\u2013587","journal-title":"Prostate"},{"key":"1273_CR14","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1186\/1471-2407-10-680","volume":"10","author":"EL Maresh","year":"2010","unstructured":"Maresh EL, Mah V, Alavi M, Horvath S, Bagryanova L, Liebeskind ES, Knutzen LA, Zhou Y, Chia D, Liu AY, Goodglick L (2010) Differential expression of anterior gradient gene AGR2 in prostate cancer. BMC Cancer 10:680","journal-title":"BMC Cancer"},{"key":"1273_CR15","first-page":"703","volume":"22","author":"FR Fritzsche","year":"2007","unstructured":"Fritzsche FR, Dahl E, Dankof A, Burkhardt M, Pahl S, Petersen I, Dietel M, Kristiansen G (2007) Expression of AGR2 in non small cell lung cancer. Histol Histopathol 22:703\u2013708","journal-title":"Histol Histopathol"},{"key":"1273_CR16","doi-asserted-by":"crossref","first-page":"7091","DOI":"10.1158\/0008-5472.CAN-11-1367","volume":"71","author":"L Dumartin","year":"2011","unstructured":"Dumartin L, Whiteman HJ, Weeks ME, Hariharan D, Dmitrovic B, Iacobuzio-Donahue CA, Brentnall TA, Bronner MP, Feakins RM, Timms JF, Brennan C, Lemoine NR, Crnogorac-Jurcevic T (2011) AGR2 is a novel surface antigen that promotes the dissemination of pancreatic cancer cells through regulation of cathepsins B and D. Cancer Res 71:7091\u20137102","journal-title":"Cancer Res"},{"key":"1273_CR17","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.humpath.2008.08.003","volume":"40","author":"P Vivekanandan","year":"2009","unstructured":"Vivekanandan P, Micchelli ST, Torbenson M (2009) Anterior gradient-2 is overexpressed by fibrolamellar carcinomas. Hum Pathol 40:293\u2013299","journal-title":"Hum Pathol"},{"key":"1273_CR18","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1365-2559.2011.04028.x","volume":"59","author":"BV Sinn","year":"2011","unstructured":"Sinn BV, Darb-Esfahani S, Wirtz RM, Budczies J, Sehouli J, Chekerov R, Dietel M, Denkert C (2011) Evaluation of a hormone receptor-positive ovarian carcinoma subtype with a favourable prognosis by determination of progesterone receptor and oestrogen receptor 1 mRNA expression in formalin-fixed paraffin-embedded tissue. Histopathology 59:918\u2013927","journal-title":"Histopathology"},{"key":"1273_CR19","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1677\/ERC-08-0338","volume":"16","author":"S Darb-Esfahani","year":"2009","unstructured":"Darb-Esfahani S, Wirtz RM, Sinn BV, Budczies J, Noske A, Weichert W, Faggad A, Scharff S, Sehouli J, Oskay-Ozcelik G, Zamagni C, De Iaco P, Martoni A, Dietel M, Denkert C (2009) Estrogen receptor 1 mRNA is a prognostic factor in ovarian carcinoma: determination by kinetic PCR in formalin-fixed paraffin-embedded tissue. Endocr Relat Cancer 16:1229\u20131239","journal-title":"Endocr Relat Cancer"},{"key":"1273_CR20","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/jcp.2007.049478","volume":"61","author":"WG McCluggage","year":"2008","unstructured":"McCluggage WG (2008) My approach to and thoughts on the typing of ovarian carcinomas. J Clin Pathol 61:152\u2013163","journal-title":"J Clin Pathol"},{"key":"1273_CR21","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1002\/cncr.23354","volume":"112","author":"A Noske","year":"2008","unstructured":"Noske A, Weichert W, Niesporek S, R\u00f6ske A, Buckendahl AC, Koch I, Sehouli J, Dietel M, Denkert C (2008) Expression of the nuclear export protein chromosomal region maintenance\/exportin 1\/Xpo1 is a prognostic factor in human ovarian cancer. Cancer 112:1733\u20131743","journal-title":"Cancer"},{"key":"1273_CR22","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.1158\/1078-0432.CCR-04-2509","volume":"11","author":"RT Marquez","year":"2005","unstructured":"Marquez RT, Baggerly KA, Patterson AP, Liu J, Broaddus R, Frumovitz M, Atkinson EN, Smith DI, Hartmann L, Fishman D, Berchuck A, Whitaker R, Gershenson DM, Mills GB, Bast RC Jr, Lu KH (2005) Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon. Clin Cancer Res 11:6116\u20136126","journal-title":"Clin Cancer Res"},{"key":"1273_CR23","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1158\/1078-0432.CCR-05-1110","volume":"12","author":"FW Wamunyokoli","year":"2006","unstructured":"Wamunyokoli FW, Bonome T, Lee JY, Feltmate CM, Welch WR, Radonovich M, Pise-Masison C, Brady J, Hao K, Berkowitz RS, Mok S, Birrer MJ (2006) Expression profiling of mucinous tumors of the ovary identifies genes of clinicopathologic importance. Clin Cancer Res 12:690\u2013700","journal-title":"Clin Cancer Res"},{"key":"1273_CR24","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1756-9966-29-62","volume":"29","author":"GE Rice","year":"2010","unstructured":"Rice GE, Edgell TA, Autelitano DJ (2010) Evaluation of midkine and anterior gradient 2 in a multimarker panel for the detection of ovarian cancer. J Exp Clin Cancer Res 29:62","journal-title":"J Exp Clin Cancer Res"},{"key":"1273_CR25","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1042\/CS20090537","volume":"118","author":"TA Edgell","year":"2010","unstructured":"Edgell TA, Barraclough DL, Rajic A, Dhulia J, Lewis KJ, Armes JE, Barraclough R, Rudland PS, Rice GE, Autelitano DJ (2010) Increased plasma concentrations of anterior gradient 2 protein are positively associated with ovarian cancer. Clin Sci (Lond) 118:717\u2013725","journal-title":"Clin Sci (Lond)"},{"key":"1273_CR26","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/sj.bjc.6600740","volume":"88","author":"GC Fletcher","year":"2003","unstructured":"Fletcher GC, Patel S, Tyson K, Adam PJ, Schenker M, Loader JA, Daviet L, Legrain P, Parekh R, Harris AL, Terrett JA (2003) hAG-2 and hAG-3, human homologues of genes involved in differentiation, are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene C4.4a and dystroglycan. Br J Cancer 88:579\u2013585","journal-title":"Br J Cancer"},{"key":"1273_CR27","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jim.2012.01.013","volume":"378","author":"TA Gray","year":"2012","unstructured":"Gray TA, Maclaine NJ, Michie CO, Bouchalova P, Murray E, Howie J, Hrstka R, Maslon MM, Nenutil R, Vojtesek B, Langdon S, Hayward L, Gourley C, Hupp TR (2012) Anterior gradient-3: a novel biomarker for ovarian cancer that mediates cisplatin resistance in xenograft models. J Immunol Methods 378:20\u201332","journal-title":"J Immunol Methods"},{"key":"1273_CR28","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1097\/PAS.0b013e318212ae22","volume":"35","author":"ER King","year":"2011","unstructured":"King ER, Tung CS, Tsang YT, Zu Z, Lok GT, Deavers MT, Malpica A, Wolf JK, LuKH BMJ, Mok SC, Gershenson DM, Wong KK (2011) The anterior gradient homolog 3 (AGR3) gene is associated with differentiation and survival in ovarian cancer. Am J Surg Pathol 35:904\u2013912","journal-title":"Am J Surg Pathol"},{"key":"1273_CR29","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11010-007-9562-y","volume":"306","author":"DR Zweitzig","year":"2007","unstructured":"Zweitzig DR, Smirnov DA, Connelly MC, Terstappen LW, O'Hara SM, Moran E (2007) Physiological stress induces the metastasis marker AGR2 in breast cancer cells. Mol Cell Biochem 306:255\u2013260","journal-title":"Mol Cell Biochem"},{"key":"1273_CR30","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1074\/mcp.M300089-MCP200","volume":"3","author":"E Pohler","year":"2004","unstructured":"Pohler E, Craig AL, Cotton J, Lawrie L, Dillon JF, Ross P, Kernohan N, Hupp TR (2004) The Barrett's antigen anterior gradient-2 silences the p53 transcriptional response to DNA damage. Mol Cell Proteomics 3:534\u2013547","journal-title":"Mol Cell Proteomics"},{"key":"1273_CR31","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc704","volume":"2","author":"AL Harris","year":"2002","unstructured":"Harris AL (2002) Hypoxia\u2014a key regulatory factor in tumour growth. Nat Rev Cancer 2:38\u201347","journal-title":"Nat Rev Cancer"},{"key":"1273_CR32","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1158\/0008-5472.CAN-04-3823","volume":"65","author":"D Liu","year":"2005","unstructured":"Liu D, Rudland PS, Sibson DR, Platt-Higgins A, Barraclough R (2005) Human homologue of cement gland protein, a novel metastasis inducer associated with breast carcinomas. Cancer Res 65:3796\u20133805","journal-title":"Cancer Res"},{"key":"1273_CR33","doi-asserted-by":"crossref","first-page":"7811","DOI":"10.1158\/0008-5472.CAN-08-1320","volume":"68","author":"V Ramachandran","year":"2008","unstructured":"Ramachandran V, Arumugam T, Wang H, Logsdon CD (2008) Anterior gradient 2 is expressed and secreted during the development of pancreatic cancer and promotes cancer cell survival. Cancer Res 68:7811\u20137818","journal-title":"Cancer Res"},{"key":"1273_CR34","doi-asserted-by":"crossref","first-page":"R32","DOI":"10.1186\/bcr2586","volume":"12","author":"KE Vanderlaag","year":"2010","unstructured":"Vanderlaag KE, Hudak S, Bald L, Fayadat-Dilman L, Sathe M, Grein J, Janatpour MJ (2010) Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-alpha and survivin. Breast Cancer Res 12:R32","journal-title":"Breast Cancer Res"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-012-1273-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-012-1273-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-012-1273-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T21:36:05Z","timestamp":1559079365000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-012-1273-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,3]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["1273"],"URL":"https:\/\/doi.org\/10.1007\/s00428-012-1273-4","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,3]]}}}